Sergei Shlychkov: Around 40% of Belarusian exports are high-tech products

06.10.2025

Innovations introduced in recent years have expanded Belarus's export portfolio and presence in the global high-tech market, Sergei Shlychkov, Chairman of the State Committee for Science and Technology, told the magazine "Economy of Belarus."

By the end of 2024, the share of high-tech exports had increased to 38.1%, reaching 205 countries and regions worldwide. This includes 369 product categories and 27 types of services. "Despite the rather extensive geography and range of knowledge-intensive exports," notes Sergei Shlychkov, "more than half are engineering products, primarily targeted at the Russian market. The industry's flagships are BELAZ and the Minsk Tractor Works. INTEGRAL OJSC, the management company of the holding company of the same name, is also demonstrating strong growth in high-tech export volumes."

According to the Chairman of the State Committee on Science and Technology, 98 innovative projects are being implemented in the current five-year period, 42% of which are based on technologies of the 5th and 6th technological waves, financed from innovation funds on preferential terms. Forty-eight state program projects have been completed, 15 of which are from the 5th and 6th technological waves. The largest projects—the design and construction of the Belarusian Nuclear Power Plant and the establishment of a high-tech, full-cycle agro-industrial production facility at BNBC CJSC—fulfill the strategic objective of ensuring the independence and enhancing the competitiveness of the economy.

"Two more are in the pipeline," Sergei Shlychkov clarified. "One of them is aimed at establishing the production of drugs based on recombinant technologies and blood plasma fractionation. A new biopharmaceutical field will be established at the Republican Scientific and Practical Center for Transfusiology and Medical Biotechnology, which will be the first in the country to produce pharmaceutical substances based on genetic engineering technologies."

The second project concerns the effectiveness of drug treatment for oncohematological patients. It involves the creation of a pilot industrial production facility for domestically produced anticancer drugs. The lead developer is the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus. A new generation of targeted therapy, more effective than chemotherapy and radiation, will be introduced into cancer treatment. The institute's own research will be used to develop a production facility for import-substituting anticancer drugs based on monoclonal antibodies.

The country's lineup of high-tech projects will also include the production of charging infrastructure for electric vehicles (OJSC Vityaz), intelligent auto components and systems meeting Euro-5 and Euro-6 emission standards (OJSC Ekran), optoelectronic technology based on thermal imaging and laser systems using image-to-optical converters and high-precision components (OJSC MMZ named after S.I. Vavilov, the management company of the BelOMO holding), precision parts and components for special equipment (OJSC Planar), and others.

*Read the full text in the journal "Economy of Belarus". 

Source: BELTA